Dysmenorrhea
Review
OA: closed
CC0
⤵ 5 in-corpus citations
⚙
AI-generated summary
by gemini-2.5-flash-lite, 2026-06-10
ⓘ
This review outlines dysmenorrhea, its risk factors, and treatment options including NSAIDs, hormonal contraception, alternative therapies, and surgical considerations for refractory cases.
Abstract
Dysmenorrhea is the leading cause of recurrent short-term school absence in adolescent girls and a common problem in women of reproductive age. Risk factors for dysmenorrhea include nulliparity, heavy menstrual flow, smoking, and depression. Empiric therapy can be initiated based on a typical history of painful menses and a negative physical examination. Nonsteroidal anti-inflammatory drugs are the initial therapy of choice in patients with presumptive primary dysmenorrhea. Oral contraceptives and depo-medroxyprogesterone acetate also may be considered. If pain relief is insufficient, prolonged-cycle oral contraceptives or intravaginal use of oral contraceptive pills can be considered. In women who do not desire hormonal contraception, there is some evidence of benefit with the use of topical heat; the Japanese herbal remedy toki-shakuyaku-san; thiamine, vitamin E, and fish oil supplements; a low-fat vegetarian diet; and acupressure. If dysmenorrhea remains uncontrolled with any of these approaches, pelvic ultrasonography should be performed and referral for laparoscopy should be considered to rule out secondary causes of dysmenorrhea. In patients with severe refractory primary dysmenorrhea, additional safe alternatives for women who want to conceive include transcutaneous electric nerve stimulation, acupuncture, nifedipine, and terbutaline. Otherwise, the use of danazol or leuprolide may be considered and, rarely, hysterectomy. The effectiveness of surgical interruption of the pelvic nerve pathways has not been established.
My notes (saved in your browser only)
Condition tags
dysmenorrheaendometriosis
MeSH descriptors
Dysmenorrhea
Anti-Inflammatory Agents, Non-Steroidal
Anti-Inflammatory Agents, Non-Steroidal
Anti-Inflammatory Agents, Non-Steroidal
Complementary Therapies
Complementary Therapies
Contraceptive Agents, Female
Contraceptive Agents, Female
Contraceptive Agents, Female
Dysmenorrhea
Dysmenorrhea
Dysmenorrhea
Dysmenorrhea
Endometriosis
Endometriosis
Endometriosis
Female
Female
Humans
Humans
Citation neighborhood
(2-hop)
Papers in the corpus that this work cites (lower rings, blue) and
that cite this one (upper rings, green). Dot size scales with the
paper's in-corpus citation count — bigger dot = more influential
within the endo/adeno field. Click a dot to open that paper.
Outer rings show 2-hop neighbours — papers reached through the
immediate citers/citees.
[ collapse to 1-hop ]
Source provenance
- europepmc
- last seen: 2026-10-04T09:26:46.659050+00:00
- openalex
- last seen: 2026-05-10T10:20:42.538694+00:00
- pubmed
- last seen: 2026-10-08T21:02:56.066688+00:00
License: CC0
· commercial use OK